The FDA has denied approval for a once-weekly version of Eli Lilly’s and Amylin Pharmaceuticals’ diabetes drug Byetta, saying that the agency needs answers to certain questions about the drug…
The FDA has required the makers of the diabetes drug Byetta to conduct additional studies to clarify the risk of pancreatitis from side effects of their medication.
Following an FDA alert issued Friday about reports of acute pancreatitis associated with use of Januvia and Janumet, Merck & Co., the maker of both diabetes drugs, issued a statement…
The FDA indicated today that the prescribing information for the diabetes drugs Januvia (sitagliptin) and Janumet (sitagliptin/metformin) will be updated to provide additional information about potential pancreatitis side effects, including…
